Standard
Association between 5-aminosalicylates in patients with IBD and risk of severe COVID-19 : an artefactual result of research methodology? / Attauabi, Mohamed; Danish COVID-IBD Study Group.
I:
Gut, Bind 70, Nr. 10, 2021, s. 2020-2022.
Publikation: Bidrag til tidsskrift › Letter › Forskning › fagfællebedømt
Harvard
Attauabi, M & Danish COVID-IBD Study Group 2021, '
Association between 5-aminosalicylates in patients with IBD and risk of severe COVID-19: an artefactual result of research methodology?',
Gut, bind 70, nr. 10, s. 2020-2022.
https://doi.org/10.1136/gutjnl-2021-324397APA
Attauabi, M., & Danish COVID-IBD Study Group (2021).
Association between 5-aminosalicylates in patients with IBD and risk of severe COVID-19: an artefactual result of research methodology? Gut,
70(10), 2020-2022.
https://doi.org/10.1136/gutjnl-2021-324397Vancouver
Attauabi M, Danish COVID-IBD Study Group.
Association between 5-aminosalicylates in patients with IBD and risk of severe COVID-19: an artefactual result of research methodology? Gut. 2021;70(10):2020-2022.
https://doi.org/10.1136/gutjnl-2021-324397Author
Attauabi, Mohamed ; Danish COVID-IBD Study Group. / Association between 5-aminosalicylates in patients with IBD and risk of severe COVID-19 : an artefactual result of research methodology?. I: Gut. 2021 ; Bind 70, Nr. 10. s. 2020-2022.
Bibtex
@article{9d7018c4c4ab4301907d1a08bbc2f39b,
title = "Association between 5-aminosalicylates in patients with IBD and risk of severe COVID-19: an artefactual result of research methodology?",
author = "Mohamed Attauabi and Jakob Seidelin and Johan Burisch and {Danish COVID-IBD Study Group}",
year = "2021",
doi = "10.1136/gutjnl-2021-324397",
language = "English",
volume = "70",
pages = "2020--2022",
journal = "Gut",
issn = "0017-5749",
publisher = "B M J Group",
number = "10",
}
RIS
TY - JOUR
T1 - Association between 5-aminosalicylates in patients with IBD and risk of severe COVID-19
T2 - an artefactual result of research methodology?
AU - Attauabi, Mohamed
AU - Seidelin, Jakob
AU - Burisch, Johan
AU - Danish COVID-IBD Study Group
PY - 2021
Y1 - 2021
U2 - 10.1136/gutjnl-2021-324397
DO - 10.1136/gutjnl-2021-324397
M3 - Letter
C2 - 33658323
VL - 70
SP - 2020
EP - 2022
JO - Gut
JF - Gut
SN - 0017-5749
IS - 10
ER -
